Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-α and Ki-67 expression

被引:109
作者
Shaaban, AM
Sloane, JP
West, CR
Foster, CS
机构
[1] Univ Liverpool, Dept Cellular & Mol Pathol, Liverpool L69 3BX, Merseyside, England
[2] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England
关键词
D O I
10.1016/S0002-9440(10)64879-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The hypothetical multistep model for breast carcinogenesis indicates that invasive carcinoma arises via a series of intermediate hyperplastic lesions through various grades of atypia. to in situ and invasive carcinoma. Non-atypical hyperplasia [hyperplasia of usual type (RUT)] is a nonobligate precursor of breast cancer. Although its further morphological subclassification is unlikely, refining is more likely to depend on defining biological markers of risk. Having assembled a cohort of benign proliferative breast lesions of known outcome, we studied the expression of estrogen receptor-alpha (ER-alpha) and Ki-67 using morphometric image analysis as well as dual-labeled immunofluorescence in HUT foci and in surrounding normal lobules of 25 patients that progressed to breast cancer and 19 controls. Those patients that progressed to breast cancer (cases) showed significantly higher ER-alpha [median, 57.00% of cells within individual HUT foci; interquartile range (IQ), 33.48 to 67.78] and Ki-67 (median, 3.82%; IQ, 0.85 to 11.28) expression in their HUT foci compared with controls (ER-alpha median, 30.27%; IQ, 19.75 to 52.50 and Ki-67 median, 0.77%; IQ, 0.0458 to 1.72, P=0.008 and <0.001). No significant difference in expression of dual-stained cells was found between cases and controls. Although normal lobules from cases showed higher ER-α expression compared with controls, this was not statistically significant. Our data point to a previously undescribed hormone-dependent pathway in this particular group of breast neoplasms and suggest the possibility of selective hormonal therapy to suppress the proliferative potential of these benign but high-risk breast lesions. The findings of this study might have important implications for improving breast cancer screening and management strategies.
引用
收藏
页码:597 / 604
页数:8
相关论文
共 29 条
[21]  
PAGE DL, 1990, CANCER, V66, P1326, DOI 10.1002/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO
[22]  
2-P
[23]   Is tamoxifen effective in prevention of breast cancer? [J].
Pritchard, KI .
LANCET, 1998, 352 (9122) :80-81
[24]  
RUSSO J, 1987, LAB INVEST, V57, P112
[25]   DEMONSTRATION OF ESTROGEN-RECEPTORS IN PARAFFIN WAX SECTIONS OF BREAST-CARCINOMA USING THE MONOCLONAL-ANTIBODY 1D5 AND MICROWAVE-OVEN PROCESSING [J].
SANNINO, P ;
SHOUSHA, S .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (01) :90-92
[26]   KI67 - STRUCTURE, FUNCTION, AND NEW ANTIBODIES [J].
SAWHNEY, N ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1992, 168 (02) :161-162
[27]   Estrogen receptor-positive proliferating cells in the normal and precancerous breast [J].
Shoker, BS ;
Jarvis, C ;
Clarke, RB ;
Anderson, E ;
Hewlett, J ;
Davies, MPA ;
Sibson, DR ;
Sloane, JP .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1811-1815
[28]   Tamoxifen suppresses histologic progression to atypia and DCIS in MCFIOAT xenografts, a model of early human breast cancer [J].
Visscher, DW ;
Nanjia-Makker, P ;
Heppner, G ;
Shekhar, PVM .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (01) :41-47
[29]   ORAL-CONTRACEPTIVE (OCP) USE INCREASES PROLIFERATION AND DECREASES ESTROGEN-RECEPTOR CONTENT OF EPITHELIAL-CELLS IN THE NORMAL HUMAN BREAST [J].
WILLIAMS, G ;
ANDERSON, E ;
HOWELL, A ;
WATSON, R ;
COYNE, J ;
ROBERTS, SA ;
POTTEN, CS .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (02) :206-210